Page last updated: 2024-08-24

ibandronic acid and Osteolysis

ibandronic acid has been researched along with Osteolysis in 12 studies

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (8.33)18.2507
2000's8 (66.67)29.6817
2010's3 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ehrenfeld, M; Mayr, D; Oduncu, F; Otto, S; Pautke, C; Troeltzsch, M1
Chung, YS; Kang, HC; Lee, T1
Lo, JC; O'Ryan, FS1
DeClerck, YA; Pollack, H; Reynolds, CP; Scadeng, M; Shimada, H; Sohara, Y; Yamada, S; Ye, W1
Bauss, F; Fischer, C; Krempien, B; Neudert, M; Seibel, MJ1
Kurth, AH1
Bauss, F; Bian, H; Garces, A; Jenkins, J; Kim, HK; Randall, TS1
Bauss, F; Ghilardi, JR; Halvorson, KG; Koewler, NJ; Mantyh, PW; Sevcik, MA; Sullivan, LJ1
Bauss, F; De Clerck, YA; Dunstan, C; Mundy, GR; Sasaki, A; Williams, PJ; Yoneda, T1
Bauss, F; Juraschek, M; Krempien, B; Seibel, MJ; Woitge, HW1
Alsina, M; Anderson, JL; Craig, F; Cruz, JC; Dallas, M; Roodman, GD; Yoneda, T1
Bauss, F; Kim, SZ; Kurth, AA; Sedlmeyer, I; Shea, M1

Reviews

1 review(s) available for ibandronic acid and Osteolysis

ArticleYear
Root resorption caused by jaw infiltration of multiple myeloma: report of a case and literature review.
    Journal of endodontics, 2014, Volume: 40, Issue:8

    Topics: Aged; Antineoplastic Agents; Bicuspid; Bone Density Conservation Agents; Diphosphonates; Follow-Up Studies; Humans; Ibandronic Acid; Male; Mandibular Neoplasms; Molar; Multiple Myeloma; Neoplasm Invasiveness; Osteolysis; Root Resorption; Stem Cell Transplantation; Tooth Mobility

2014

Other Studies

11 other study(ies) available for ibandronic acid and Osteolysis

ArticleYear
Comparative Effects of Ibandronate and Paclitaxel on Immunocompetent Bone Metastasis Model.
    Yonsei medical journal, 2015, Volume: 56, Issue:6

    Topics: Amino Acids; Animals; Biomechanical Phenomena; Bone Density; Bone Neoplasms; Bone Resorption; Diphosphonates; Ibandronic Acid; Immunocompetence; Male; Neoplasm Metastasis; Osteolysis; Paclitaxel; Rats; Rats, Sprague-Dawley

2015
Bisphosphonate-related osteonecrosis of the jaw in patients with oral bisphosphonate exposure: clinical course and outcomes.
    Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons, 2012, Volume: 70, Issue:8

    Topics: Administration, Oral; Aged; Aged, 80 and over; Alendronate; Anti-Bacterial Agents; Antirheumatic Agents; Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone Density Conservation Agents; Bone Diseases, Metabolic; Chronic Disease; Cohort Studies; Debridement; Diphosphonates; Female; Follow-Up Studies; Glucocorticoids; Humans; Ibandronic Acid; Male; Middle Aged; Osteolysis; Osteoporosis; Osteosclerosis; Retrospective Studies; Tooth Extraction; Treatment Outcome; Wound Healing

2012
Lytic bone lesions in human neuroblastoma xenograft involve osteoclast recruitment and are inhibited by bisphosphonate.
    Cancer research, 2003, Jun-15, Volume: 63, Issue:12

    Topics: Adrenal Glands; Animals; Apoptosis; Bone Neoplasms; Diphosphonates; Female; Femoral Neoplasms; Femur; Heart; Humans; Ibandronic Acid; Injections; Injections, Intravenous; Injections, Subcutaneous; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Neuroblastoma; Osteoclasts; Osteolysis; Tail; Tumor Cells, Cultured; Xenograft Model Antitumor Assays

2003
Site-specific human breast cancer (MDA-MB-231) metastases in nude rats: model characterisation and in vivo effects of ibandronate on tumour growth.
    International journal of cancer, 2003, Nov-10, Volume: 107, Issue:3

    Topics: Animals; Apoptosis; Bone Density; Bone Neoplasms; Diphosphonates; Female; Humans; Ibandronic Acid; Mammary Neoplasms, Experimental; Neoplasm Transplantation; Osteolysis; Rats; Rats, Nude; Rats, Sprague-Dawley; Transplantation, Heterologous

2003
[Oral and parenteral forms of aminobisphosphonate].
    Krankenpflege Journal, 2004, Volume: 42, Issue:3-4

    Topics: Administration, Oral; Bone Neoplasms; Bone Resorption; Breast Neoplasms; Colorectal Neoplasms; Diphosphonates; Humans; Ibandronic Acid; Infusions, Intravenous; Osteolysis; Spinal Neoplasms

2004
Ibandronate for prevention of femoral head deformity after ischemic necrosis of the capital femoral epiphysis in immature pigs.
    The Journal of bone and joint surgery. American volume, 2005, Volume: 87, Issue:3

    Topics: Animals; Bone Resorption; Diphosphonates; Epiphyses; Femur Head; Femur Head Necrosis; Ibandronic Acid; Infarction; Ischemia; Male; Osteolysis; Radiography; Swine

2005
Intravenous ibandronate rapidly reduces pain, neurochemical indices of central sensitization, tumor burden, and skeletal destruction in a mouse model of bone cancer.
    Journal of pain and symptom management, 2008, Volume: 36, Issue:3

    Topics: Animals; Biomarkers, Tumor; Bone Density Conservation Agents; Bone Neoplasms; Cell Line, Tumor; Diphosphonates; Disease Models, Animal; Ibandronic Acid; Injections, Intravenous; Male; Mice; Mice, Inbred C3H; Osteolysis; Osteosarcoma; Pain; Pain Measurement; Treatment Outcome

2008
Inhibition of osteolytic bone metastasis of breast cancer by combined treatment with the bisphosphonate ibandronate and tissue inhibitor of the matrix metalloproteinase-2.
    The Journal of clinical investigation, 1997, May-15, Volume: 99, Issue:10

    Topics: Animals; Antineoplastic Agents; Bone Neoplasms; Bone Resorption; Breast Neoplasms; Cell Survival; Diphosphonates; Female; Genetic Therapy; Heart Ventricles; Humans; Ibandronic Acid; Mice; Mice, Nude; Neoplasm Invasiveness; Osteolysis; Protein Biosynthesis; Tibia; Tissue Inhibitor of Metalloproteinase-2; Transfection; Transplantation, Heterologous; Tumor Cells, Cultured

1997
Association between histomorphometry and biochemical markers of bone turnover in a longitudinal rat model of parathyroid hormone-related peptide (PTHrP)-mediated tumor osteolysis.
    Bone, 2000, Volume: 26, Issue:5

    Topics: Animals; Biomarkers; Carcinoma 256, Walker; Diphosphonates; Female; Ibandronic Acid; Longitudinal Studies; Models, Biological; Osteolysis; Parathyroid Hormone-Related Protein; Proteins; Rats; Rats, Wistar

2000
Ibandronate decreases bone disease development and osteoclast stimulatory activity in an in vivo model of human myeloma.
    Experimental hematology, 2001, Volume: 29, Issue:4

    Topics: Animals; Bone Diseases; Bone Marrow Cells; Cell Division; Cell Survival; Diphosphonates; Disease Models, Animal; Humans; Hypercalcemia; Ibandronic Acid; Immunoglobulin G; Immunoglobulin kappa-Chains; Leukemia, Plasma Cell; Mice; Mice, SCID; Multiple Myeloma; Neoplasm Transplantation; Osteoclasts; Osteolysis; Paraplegia; Tumor Cells, Cultured

2001
Ibandronate treatment decreases the effects of tumor-associated lesions on bone density and strength in the rat.
    Bone, 2002, Volume: 30, Issue:1

    Topics: Animals; Biomechanical Phenomena; Bone Density; Bone Neoplasms; Diphosphonates; Female; Fractures, Bone; Humans; Ibandronic Acid; Mammary Neoplasms, Experimental; Osteolysis; Rats; Rats, Sprague-Dawley; Sarcoma, Experimental

2002